Cite Filings / ELOX / 0001144204-14-038751
Feed Companies Filings Check
Sign in
SC 13D/A

Beneficial Ownership Report

Eloxx Pharmaceuticals, Inc. · Filed 2014-06-20 · Acc 0001144204-14-038751

Documents 1

  • SC 13D/A Beneficial Ownership Report , v381924_sc13da.htm

Around this filing

  • 2014-12-29 SC 13D/A Beneficial Ownership Report
  • 2014-06-20 SC 13D/A Beneficial Ownership Report
  • 2014-06-19 SC 13D/A Beneficial Ownership Report
  • 2014-06-17 4 Options or other derivatives
  • 2014-06-16 4 Options or other derivatives
  • 2014-06-16 8-K Material agreement · Unregistered share sale · Shareholder rights changed
  • 2014-06-16 4 Options or other derivatives

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-13 SCHEDULE 13G/A · Coastlands Capital LP 9.99%
  2. 2026-06-05 SCHEDULE 13G/A · Domicilium Capital Partners LLC 4.9%
  3. 2024-08-20 SC 13D/A · Advent Life Sciences LLP 3.98%
  4. 2023-02-13 SC 13G/A · Roche Finance Ltd 0.1%
  5. 2022-02-14 SC 13G/A · Roche Finance Ltd 5.8%
  6. 2022-02-03 SC 13D/A · LSP V Coöperatieve U.A 3.4%
  7. 2021-06-29 SC 13G · Gurnet Point L.P. 5.7%
  8. 2021-06-14 SC 13G · Roche Finance Ltd 5.3%
  9. 2021-05-21 SC 13D/A · Pontifax Management 4 G.P. (2015) Ltd. 8.66%
Loading v381924_sc13da.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…